Cargando…

Efficacy and Tolerability of Ziprasidone Use in Children and Adolescents, a Systemic Review and Meta Analysis

INTRODUCTION: Ziprasidone is an atypical antipsychotic that has demonstrated efficacy for the treatment of bipolar disorder and schizophrenia. There is some preliminary evidence for Ziprasidone use in children and adolescents with several open label studies and some randomized control trials, theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wadhwa, A., Sareen, A., Soeung, C., Penuelas-Calvo, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565114/ http://dx.doi.org/10.1192/j.eurpsy.2022.1076

Ejemplares similares

Tolerability of Ziprasidone Use in Children and Adolescents: A Prisma Model: Systematic Review and Meta-Analysis
por: Jay, J., et al.
Publicado: (2022)

Factors associated with first suicide attempt vs. re-attempt in children and adolescents: A systematic review and meta-analysis
por: Abascal-Peiró, S., et al.
Publicado: (2023)

Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone
por: Khan, Afshan A, et al.
Publicado: (2010)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012)

Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

Efficacy of Ziprasidone in Controlling Agitation during Post-Traumatic Amnesia
por: Noé, Enrique, et al.
Publicado: (2007)

PS153. Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
por: Heo, Jung Yoon, et al.
Publicado: (2016)

Evidence review and clinical guidance for the use of ziprasidone in Canada
por: Gardner, David M, et al.
Publicado: (2013)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

TMS use in Depressive disorder in Youth
por: Wadhwa, A., et al.
Publicado: (2022)

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
por: Younce, John R., et al.
Publicado: (2019)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

Nonisothermal Kinetics Analysis of the Dehydration of Ziprasidone Hydrochloride Monohydrate by Thermogravimetry
por: Ravikiran, A., et al.
Publicado: (2013)

A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

The efficacy of cognitive remediation in children and adolescents: results from a new meta-analysis.
por: Moscoso, A.
Publicado: (2023)

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study
por: Jangro, William C, et al.
Publicado: (2009)

The Association Between Reading the Mind in the Eyes Test Performance and Intelligence Quotient in Children and Adolescents With Asperger Syndrome
por: Peñuelas-Calvo, Inmaculada, et al.
Publicado: (2021)

Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021)

Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment
por: Boaden, Katharine, et al.
Publicado: (2020)

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine
por: Bartolommei, Natalia, et al.
Publicado: (2014)

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023)

Parenteral Sustained Release Lipid Phase-Transition System of Ziprasidone: Fabrication and Evaluation for Schizophrenia Therapy
por: Khan, Urooj A, et al.
Publicado: (2020)

Memory deficits in children and adolescents with psychotic disorders: A systematic review and meta-analysis
por: Rodríguez Toscano, E., et al.
Publicado: (2023)

QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis
por: Li, Xian-Bin, et al.
Publicado: (2014)

Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl
por: AJ, Rajamma, et al.
Publicado: (2012)

Ziprasidone and its Association with Sudden Cardiac Death - A Case Report
por: Sidana, Ajeet, et al.
Publicado: (2004)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female
por: Wilson, Alphonso, et al.
Publicado: (2020)

Restless legs syndrome following the use of ziprasidone: a case report
por: Zhu, Cuizhen, et al.
Publicado: (2020)

F53. DOSE REDUCTION OF HIGH-DOSE FIRST-GENERATION ANTIPSYCHOTICS OR SWITCH TO ZIPRASIDONE IN LONG-STAY PATIENTS WITH SCHIZOPHRENIA: A 1-YEAR DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
por: Bogers, Jan, et al.
Publicado: (2018)

Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
por: Hagi, K., et al.
Publicado: (2021)

Efficacy and Metabolic Influence on Blood-Glucose and Serum Lipid of Ziprasidone in the Treatment of Elderly Patients with First-Episode Schizophrenia
Publicado: (2017)

Literature review and economic evaluation of oral and intramuscular ziprasidone treatment among patients with schizophrenia in China
por: Yeh, Yu-Chen, et al.
Publicado: (2019)

Ziprasidone, haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia: A network meta-analysis
por: Su, Liang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4b8cn571d2tmag1iejce27cu1e